Counterfeit Drug Detection

Non-invasive, non-destructive authentication of packaged medicines

 

Safe Medicines, Good Health: In 2013, the United Nations Human Rights Council (UNHCR) adopted a resolution (A/HRC/RES12/24) on access to medicines that stressed “the responsibility of States to ensure access to all, without discrimination, of medicines, in particular essential medicines, that are affordable, safe, effective and of good quality”.

 

Current methods for authenticating medicines rely on optical spectroscopy or wet chemistry and for best effect require that the pill be removed from the packaging prior to testing, meaning that only a small number of packets from a suspect consignment can be tested for economic reasons. 

 

The Medicines Authentication Unit within the Department of Informatics, King’s College London, has developed an authentication approach based on radiofrequency spectroscopy. The medicines can be examined without being removed from the packaging, making it possible to test all packets in a suspect consignment without the economic cost associated with current methods. Another advantage is that this allows detection of counterfeit as well as substandard and degraded drugs. The method is designed for solids and is suited for pills, powders and suspensions.

 

Advantages

 

-       Non-invasive and non-destructive

-       Can be used on packaged medicines and consignments in parcels

-       Can detect counterfeit as well as substandard and degraded drugs

-       Can determine material properties such as form, physical processing and other effects e.g. ageing

-       Adaptable to mobile operation

-       Simple Yes/ No response

 

Patent Portfolio Status

 

-       Method of and Apparatus for NQR testing - US granted (US 5,583,437)

-       NQR Methods and Apparatus - US granted (US 5,457,385)

-       Method of Nuclear Quadrupole Resonance Testing and method of configuring apparatus for Nuclear Quadrupole Resonance testing - US granted (US 6,222,364)

-       Enhancing Signals - US granted (US 8,618,798) and EU pending

 

Technical Development

 

There are currently two proof-of-principle prototypes in use at King’s College London, one configured to examine individual packets, and the other to inspect consignments sent through the mail.  In the course of development of these two prototypes, the Medicines Authentication Unit successfully identified instances of medicines falsification across a range of therapeutic categories.  Both devices work on a simple “red light/ green light - yes/ no” output and do not require operators to have any technical or scientific background.

 

Figure: Illustration of one of the prototypes in use

 

Technical Background

 

Quadrupole Resonance Spectroscopy (QR) is a radiofrequency-based spectroscopic technique that returns signals from solid materials such as pharmaceutical active ingredients specific to the chemistry of the material under investigation.  These signals are characteristic of not just to the material present, but also the amount of material present, the form (e.g. polymorph, ratio of stereoisomers) physical processing (e.g. loose powder, pressed pill) and even effects due to ageing.  As the technology is radiofrequency-based, it is able to work through non-metallic packaging, eliminating the need to remove the medicines from their packaging prior to analysis.  Not all molecules contain QR-sensitive elements, but, as both nitrogen-14 and Chlorine-35 are QR-sensitive, most active pharmaceutical ingredients do .  There are no consumables required for quadrupole resonance, simply an electrical supply that can come from rechargeable batteries.  Also, unlike with laser-based methods, no special precautions are required for working with radiofrequency electromagnetic radiation, making the technology ideal for adaptation for mobile operation.

 

Figure: Two cases of medicines falsification successfully identified using QR, illustrating that the method is both qualitative and quantitative.  Orlistat is a slimming aid, and metakelfin an anti-malarial.  The metakelfin case shows that even when the correct material is present, if it is not present in the correct amount QR still spots the deception.

 

Patent Information:
For Information, Contact:
Mugdha Joshi
IP & Licensing Manager
King's College London
mugdha.joshi@kcl.ac.uk
Inventors:
Keywords: